News
The acquisition is expected to cost almost €65 million and will secure domestic pharmaceutical capacity, in peacetime and in times of crisis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback